We are live on ! Find out more
GCM

Gladius Capital Management Portfolio holdings

AUM $1.65B
1-Year Est. Return 25.75%
This Fund
S&P 500
This Quarter Est. Return
-17.23%
1 Year Est. Return
+25.75%
3 Year Est. Return
+78.03%
5 Year Est. Return
+67.88%
10 Year Est. Return
+218.88%
AUM
$1.93B
AUM Growth
+$574M
Cap. Flow
+$864M
Cap. Flow %
44.87%
Top 10 Hldgs %
51.25%
Holding
447
New
182
Increased
81
Reduced
82
Closed
99

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$40M
2
GILD icon
Gilead Sciences
GILD
+$18.9M
3
TSLA icon
Tesla
TSLA
+$8.3M
4
WFC icon
Wells Fargo
WFC
+$5.87M
5
V icon
Visa
V
+$3.61M

Sector Composition

Rank Sector Weight
1 Technology 3.14%
2 Industrials 2.22%
3 Communication Services 1.34%
4 Financials 1.2%
5 Consumer Staples 1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBYI icon
301
Puma Biotechnology
PBYI
$391M
$28K ﹤0.01%
+9,811
New +$24.4K
IP icon
302
International Paper
IP
$21.9B
$27K ﹤0.01%
639
-3,925
-86% -$182K
NTGR icon
303
NETGEAR
NTGR
$648M
$27K ﹤0.01%
+1,406
New +$28.7K
TITN icon
304
Titan Machinery
TITN
$423M
$27K ﹤0.01%
+1,176
New +$29.3K
AMNB
305
DELISTED
American National Bankshares Inc
AMNB
$27K ﹤0.01%
+779
New +$27.6K
CTMX icon
306
CytomX Therapeutics
CTMX
$690M
$25K ﹤0.01%
+13,172
New +$25.2K
HFWA icon
307
Heritage Financial
HFWA
$1.23B
$25K ﹤0.01%
+970
New +$24.2K
OOMA icon
308
Ooma
OOMA
$590M
$24K ﹤0.01%
+2,016
New +$26.8K
PTCT icon
309
PTC Therapeutics
PTCT
$5.68B
$24K ﹤0.01%
+598
New +$21K
AQB icon
310
AquaBounty Technologies
AQB
$4.73M
$22K ﹤0.01%
+638
New +$19.5K
KW
311
DELISTED
Kennedy-Wilson Holdings
KW
$22K ﹤0.01%
+1,138
New +$24.5K
SCS
312
DELISTED
Steelcase
SCS
$22K ﹤0.01%
2,003
-6,226
-76% -$72K
ATNI icon
313
ATN International
ATNI
$379M
$21K ﹤0.01%
438
-1,284
-75% -$54.4K
TAP icon
314
Molson Coors Class B
TAP
$7.86B
$21K ﹤0.01%
380
-2,323
-86% -$125K
VOYA icon
315
Voya Financial
VOYA
$9.07B
$21K ﹤0.01%
+350
New +$22.5K
ATCX
316
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$21K ﹤0.01%
+3,865
New +$36.6K
DINO icon
317
HF Sinclair
DINO
$15.8B
$20K ﹤0.01%
441
-5,047
-92% -$226K
ELAN icon
318
Elanco Animal Health
ELAN
$12.8B
$20K ﹤0.01%
+971
New +$23K
ANAB icon
319
AnaptysBio
ANAB
$1.59B
$19K ﹤0.01%
+892
New +$19.8K
CNXN icon
320
PC Connection
CNXN
$2.16B
$19K ﹤0.01%
+426
New +$20.2K
MRNA icon
321
Moderna
MRNA
$21.9B
$18K ﹤0.01%
+121
New +$17.3K
SAGE
322
DELISTED
Sage Therapeutics
SAGE
$18K ﹤0.01%
+539
New +$18.1K
TBCH
323
Turtle Beach Corp
TBCH
$254M
$18K ﹤0.01%
+1,411
New +$24K
AGIO icon
324
Agios Pharmaceuticals
AGIO
$1.82B
$17K ﹤0.01%
+758
New +$17.1K
LGF.B
325
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$17K ﹤0.01%
1,905
-2,426
-56% -$27.6K

Similar funds

Gladius Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Gladius Capital Management held 447 positions worth $1.93B, up 42% from $1.35B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Gladius Capital Management deployed $864M of net new capital in Q2 2022, opening 182 new positions and adding to 81 existing holdings. Its largest new stake was Apple: 122,194 shares worth $16.7M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 1.3% a quarter earlier, followed by Industrials and Communication Services.

On the sell side, the largest reduction was Gilead Sciences, an estimated $18.9M trimmed.

  • Gladius Capital Management's largest Q2 2022 buy was Apple: 122,194 shares worth $16.7M.
  • Gladius Capital Management added most to iShares MSCI EAFE ETF in Q2 2022, an estimated $109M increase.
  • Gladius Capital Management's biggest Q2 2022 reduction was Gilead Sciences, cutting an estimated $18.9M.
  • Gladius Capital Management fully exited Invesco QQQ Trust in Q2 2022, selling an estimated $40M.
  • Gladius Capital Management's ten largest holdings make up 51% of its $1.93B portfolio in Q2 2022.
  • Gladius Capital Management opened 182 new positions and closed 99 in Q2 2022.
  • Gladius Capital Management's portfolio value rose 42% quarter-over-quarter to $1.93B.

Based on Gladius Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.